| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.6M | -39.5% |
| Cost of Revenue | $3.3M | +44.6% |
| R&D Expense | $8.2M | -25.1% |
| SG&A Expense | $8.9M | -10.6% |
| Operating Income | -$34.6M | -48.5% |
| Interest Expense | $3.3M | -32.1% |
| Pre-tax Income | -$37.3M | -7.3% |
| Income Tax | $44K | +0.0% |
| Net Income | -$37.3M | -7.1% |
| EPS (Basic) | -$15.27 | +33.3% |
| EPS (Diluted) | -$15.27 | +33.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.4M | -79.4% |
| Accounts Receivable | $514K | -56.1% |
| Inventory | $3.6M | -22.6% |
| Current Assets | $10.7M | -73.2% |
| Total Assets | $25.8M | -64.0% |
| Current Liabilities | $10.6M | -46.8% |
| Long-term Debt | $4.9M | -32.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.4M | +4.8% |
| Capital Expenditures | $591K | -70.2% |
| Investing Cash Flow | -$591K | +70.2% |
| Financing Cash Flow | -$6.7M | -114.2% |
| Free Cash Flow | -$21.0M | +10.3% |
| Total Liabilities |
| $18.2M |
| -40.1% |
| Stockholders' Equity | $7.6M | -81.6% |